98%
921
2 minutes
20
Background: Mechanical insufflation-exsufflation (MI-E) is a noninvasive technique performed to simulate cough and remove sputum from proximal airways. To date, the effects of MI-E on critically ill patients on invasive mechanical ventilation are not fully elucidated. In this randomized crossover trial, we evaluated the efficacy and safety of MI-E combined to expiratory rib cage compressions (ERCC).
Methods: Twenty-six consecutive subjects who were sedated, intubated, and on mechanical ventilation > 48 h were randomized to perform 2 sessions of ERCC with or without additional MI-E before tracheal suctioning in a 24-h period. The primary outcome was sputum volume following each procedure. Secondary end points included effects on respiratory mechanics, hemodynamics, and safety.
Results: In comparison to ERCC alone, median (interquartile range) sputum volume cleared was significantly higher during ERCC+MI-E (0.42 [0-1.39] mL vs 2.29 [1-4.67] mL, < .001). The mean ± SD respiratory compliance improved in both groups immediately after the treatment, with the greater improvement in the ERCC+MI-E group (54.7 ± 24.1 mL/cm HO vs 73.7 ± 35.8 mL/cm HO, < .001). Differences between the groups were not significant ( = .057). Heart rate increased significantly in both groups immediately after each intervention ( < .05). Additionally, a significant increase in oxygenation was observed from baseline to 1 h post-intervention in the ERCC+MI-E group ( < .05). Finally, several transitory hemodynamic variations occurred during both interventions, but these were nonsignificant and were considered clinically irrelevant.
Conclusions: In mechanically ventilated subjects, MI-E combined with ERCC increased the sputum volume cleared without causing clinically important hemodynamic changes or adverse events. (ClinicalTrials.gov registration: NCT03316079.).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4187/respcare.08641 | DOI Listing |
Clin Transl Allergy
September 2025
Second Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Background: Induced sputum cell count is crucial for assessing airway inflammatory phenotypes. This study investigated how aspirin-induced bronchospasm affects sputum cell counts in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD), comparing systemic versus local aspirin administration.
Methods: Seventy-eight patients with N-ERD and 39 with aspirin-tolerant asthma (ATA) participated.
Lung India
September 2025
Department of Pulmonary Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.
Bronchiectasis is a chronic airway disease with recurrent exacerbations and hospitalisations. No inhaled antibiotic has shown consistently beneficial effects in trials. This review analyses the evidence on inhaled antibiotics in non-cystic fibrosis bronchiectasis (NCFB), identifies patient traits for their use, and highlights research gaps.
View Article and Find Full Text PDFERJ Open Res
July 2025
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Background: The relationship between pre-treatment levels of blood eosinophil count (BEC), fractional exhaled nitric oxide ( ) and sputum eosinophils (Sp-EOS) and treatment response to monoclonal antibodies (mAbs) in severe eosinophilic asthma (SEA) remains unclear. We evaluated pre-treatment levels of BEC, , Sp-EOS and their combinations as predictors of treatment responses in patients with SEA undergoing anti-interleukin (IL)-5/IL-5Rα or anti-IL-4Rα antibody therapies.
Methods: The study included 153 adult patients with SEA (59 anti-IL-5/IL-5Rα and 94 anti-IL-4Rα users).
Clin Microbiol Infect
August 2025
Cystic fibrosis Center Aarhus, Department of Infectious Diseases, Aarhus University Hospital, Denmark; Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, Denmark; Cystic fibr
Objectives: Cystic fibrosis (CF) is a severe autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. The resulting dysfunction of the CFTR chloride channel leads to dehydrated mucus, reduced mucociliary clearance, and pulmonary infections. Introduction of the CFTR modulator elexacaftor/tezacaftor/ivacaftor (ETI) has revolutionized treatment of people with CF (pwCF).
View Article and Find Full Text PDFInt J Lang Commun Disord
August 2025
Department of Language and Communication Sciences, School of Health and Medical Sciences, City St George's, University of London, London, UK.
Background: People with laryngectomy who use a tracheoesophageal voice prosthesis for communication experience changes to respiratory function resulting in reduced breath support and increased secretions. This impacts tracheoesophageal voice quality and volume. Expiratory muscle strength training (EMST) is an effective treatment for cough management, voice and respiratory function in other clinical populations, such as neurodegenerative conditions and benign voice disorders.
View Article and Find Full Text PDF